IM Cannabis Leverages Restructuring Deal to Reduce Financial Strain
IM Cannabis enters a definitive deal to sell its subsidiary to Slil, aiming to boost equity and focus on Israeli assets.
IM Cannabis is selling one of its business pieces to another company to get money and focus on what it does best in Israel. When a company sells parts of itself, watch if it helps them become stronger or if they're just trying to survive tough times.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.